...
首页> 外文期刊>Journal of Korean medical science. >Incidence and Mortality Rates of Thoracic Aortic Dissection in Korea – Inferred from the Nationwide Health Insurance Claims
【24h】

Incidence and Mortality Rates of Thoracic Aortic Dissection in Korea – Inferred from the Nationwide Health Insurance Claims

机译:韩国胸主动脉解剖的发病率和死亡率 - 从全国保健保险索赔推断出来

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Aortic dissection (AD) is one of the most catastrophic diseases and is associated with high morbidity and mortality. The aim of this study is to investigate the hospital incidence and mortality rates of thoracic AD in Korea using a nationwide database.METHODS:We conducted a nationwide population-based study using the health claims data of the National Health Insurance Service in Korea. From 2005 to 2016, adult patients newly diagnosed with AD were included. All patients were divided into the following four subgroups by treatment: type A surgical repair (TASR), type B surgical repair (TBSR), thoracic endovascular aortic repair (TEVAR), and medical management (MM). The incidence rate, mortality rate, and risk factors of in-hospital mortality were evaluated.RESULTS:In total, 18,565 patients were newly diagnosed with AD (TASR, n = 4,319 [23.3%]; TBSR, n = 186 [1.0%]; TEVAR, n = 697 [3.8%]; MM, n = 13,363 [72.0%]). The overall AD incidence rate was 3.76 per 100,000 person-years and exhibited a gradual increase during the study period (3.29 to 4.82, P 0.001). The overall in-hospital mortality rate was 10.84% and remained consistent (P = 0.57). However, the in-hospital mortality rate decreased in the TASR subgroup (18.23 to 11.27%, P = 0.046). An older age, the female sex, hypertension, and chronic kidney disease were independent risk factors for in-hospital mortality.CONCLUSION:The incidence of thoracic AD has gradually increased in Korea. The in-hospital mortality in the TASR subgroup decreased over the decade, although the overall mortality of AD patients did not change.? 2020 The Korean Academy of Medical Sciences.
机译:背景:主动脉解剖(AD)是最灾难性的疾病之一,与高发病率和死亡率有关。本研究的目的是使用全国范围的数据库调查韩国胸部广告的医院发病率和死亡率。方法:我们在韩国国家健康保险服务的健康声称数据进行了一项基于全国人口的研究。从2005年到2016年,包括新诊断的成人患者。通过治疗将所有患者分为以下四个亚组:型手术修复(TASR),B型外科修复(TBSR),胸腔血管内主动脉修复(TEVAR)和医疗管理(MM)。评估了医院内死亡率的发病率,死亡率和危险因素。结果:总共有18,565名患者用AD新诊断(TASR,N = 4,319 [23.3%]; TBSR,N = 186 [1.0%] ; Tevar,n = 697 [3.8%]; mm,n = 13,363 [72.0%])。整体广告发病率为每10万人3.76人,在研究期间逐步增加(3.29至4.82,P <0.001)。整体院内死亡率为10.84%,仍然一致(P = 0.57)。然而,TASR亚组中,院内死亡率降低(18.23至11.27%,P = 0.046)。年龄较大的年龄,女性,高血压和慢性肾疾病是住院内死亡率的独立危险因素。结论:胸部广告的发病率在韩国逐渐增加。 TASR亚组中的住院死亡率在十年减少,尽管AD患者的总体死亡率没有变化。 2020韩国医学科学院。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号